Metropolitan Life Insurance Company (MetLife)’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
Metropolitan Life Insurance Company (MetLife)'s TWST Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 3,035 shares — an estimated $104K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in TWST in Q2 2019 and held it in 20 quarters. The position peaked at $1.76M in Q2 2021. 263 funds tracked by Wall St. Rank hold TWST as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,035 Twist Bioscience shares in Q2 2024, an estimated $104K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Twist Bioscience in Q2 2019 and held it in 20 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Twist Bioscience position peaked at $1.76M in Q2 2021.
- 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.